EligibleTrials

Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation

Recruiting · NCT04343430 · Interventional (participants receive a specific treatment) · Lead sponsor: Central Hospital, Nancy, France

View the official record on ClinicalTrials.gov →
Heart failure

Interventions studied

Biological: Blood sample retrieved for biological assessment and biobankingCardio-pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastographyClinical examination centered on congestionKansas City Cardiomyopathy Questionnaire (KCCQ)Telephone interview

What this trial is about

The AHF-CODE preserved study is a prospective, non-randomized, monocenter study performed in patients with heart failure with preserved ejection fraction admitted for worsening heart failure. The main objective of the AHF-CODE preserved study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk of all cause death or rehospitalization for acute heart failure within 3 months of hospital discharge.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.